Consultant- Cytogenetics
Posted 473 days ago, which is unusual. The employer's own board was still carrying it when we last read it, 1 day ago.
This is the employer's own posting, not a copy on a job board.
What we know
Is it still open?
Confirmed still open
Last checked 1d ago — checked against the employer's own applicant tracking system, which is the company answering directly.
We re-read the employer's own applicant tracking system and the posting was still there. That is the company answering directly.
How old is it?
Posted 473d ago
The date the source published, not the day we noticed it (2025-08-01). Last seen at its source 1d ago.
We have tracked this listing since 12 Nov 2026 (4 days). The employer's own board has carried it every time we have read it, most recently 1 day ago.
Is it remote?
Chennai - Remote (Home Based)
That is the location the employer filed this posting under. Quoted as written — we do not re-word the source's own location.
Who may apply?
Chennai
The description states no restriction of its own. This is the source's own tag.
Carried by 1 source
-
Workday employer's own board first seen 4d ago · last seen 1d ago
The listing
Job Title
Consultant- Cytogenetics
Location(s)
Chennai - Remote (Home Based)About Us
Revvity is a developer and provider of end-to-end solutions designed to help scientists, researchers, and clinicians solve the world’s greatest health challenges. We pair the enthusiasm of an industry disruptor with the experience of a longtime leader. Our team of 11,000+ colleagues from around the globe are vital to our success and the reason we’re able to push boundaries in pursuit of better human health.
Find your future at Revvity
- Checking karyotype images and advising the results
- Checking karyotype images and confirm team’s results and nomenclature
- Ensure ICSN nomenclature is followed appropriately for all cases reported out
- Work timing would be based on either
- Minimum cases per day as per mutually agreed terms
- Minimum time of 2 to 3 hrs per day as mutually agreed
- Training the team to be competent in identification and representing the karypotype abnormalities as per ISCN 2020